Table 3B.
Comparison of novel plasma biomarkers between high and intermediate risk groups
| Biomarker | High risk | Intermediate risk | Age, sex and BMI adjusted p value | ||
|---|---|---|---|---|---|
| N | Mean ± SD | N | Mean ± SD | ||
| TG (mg/dl) | 81 | 179.12 ± 134.63 | 227 | 164.52 ± 79.90 | 0.000 |
| LDL (mg/dl) | 78 | 125.664 ± 29.129 | 224 | 126.622 ± 38.392 | 0.033 |
| Apo A1 (g/l) | 81 | 1.211 ± 0.246 | 226 | 1.210 ± 0.239 | 0.042 |
| Apo B 100 (g/l) | 81 | 1.122 ± 0.292 | 226 | 1.118 ± 0.284 | 0.000 |
| Lp(a) (mg/dl) | 75 | 29.15 ± 27.75 | 201 | 23.52 ± 29.34 | 0.139 |
| CRP (ug/dl) | 51 | 5.363 ± 6.197 | 96 | 4.474 ± 5.804 | 0.000 |
| hsCRP (μg/dl) | 34 | 4.340 ± 4.370 | 100 | 4.104 ± 5.654 | 0.000 |
| IL6 (pg/ml) | 41 | 4.270 ± 2.309 | 77 | 4.231 ± 7.7457 | 0.020 |
| OxLDL (mu/l) | 52 | 64878.549 ± 21058.379 | 93 | 64200.956 ± 17056.390 | 0.673 |
| sICAM (ng/ml) | 28 | 273.349 ± 127.368 | 56 | 241.891 ± 64.331 | 0.334 |
| p-selectin (ng/ml) | 31 | 51.810 ± 18.444 | 64 | 52.090 ± 17.807 | 0.375 |
| PAI-1 (ng/ml) | 54 | 68.490 ± 62.923 | 138 | 63.096 ± 41.998 | 0.000 |
| Fibrinogen (g/l) | 81 | 4.081 ± 1.014 | 225 | 3.881 ± 0.863 | 0.000 |
| FVII.c (%) | 81 | 112.30 ± 28.20 | 225 | 117.79 ± 23.59 | 0.000 |
| Adiponectin (ng/ml) | 28 | 6138.446 ± 4174.458 | 52 | 5798.520 ± 3044.120 | 0.001 |
| Leptin (ng/ml) | 27 | 30.530 ± 21.842 | 52 | 25.3465 ± 17.494 | 0.000 |
| CMV (IU/ml) | 80 | 14.603 ± 18.162 | 223 | 12.961 ± 11.709 | 0.069 |
| C.pneumoniae (Al) | 81 | 0.7048 ± 0.3276 | 226 | 0.6714 ± 0.4017 | 0.034 |
| H.pylori (Uarb/ml) | 25 | 31.817 ± 59.700 | 49 | 26.735 ± 35.417 | 0.911 |
| HSV 1 (IU/ml) | 25 | 1.234 ± 0.998 | 49 | 1.189 ± 1.019 | 0.456 |
| HSP 65 (mg/ml) | 81 | 3.462 ± 6.083 | 227 | 2.115 ± 4.946 | 0.043 |